Biotech Values

[vinmantoo]

At this early point 50% are happy and 50% have a frown line. Over time the pnjectors should get a better handle on it.

Jbog, Thanks. That sounds good to me.

The pumping of Daxify's claims might have put the patients expectations too high.

I think most of the expectations are from people on this board. I don't think it is RVNC is pushing the twice as long scenario, just that is lasts longer.

I place more importance to the upcoming FDA decision on the CD indication rather than on the Q2 results for the cosmetic usage. Obviously I would prefer blowout numbers but it isn't that critical, at least not now.